Clinical experiences with vecuronium in children.
The neuromuscular blocking effects of vecuronium have been investigated clinically in children regarding its efficacy and safety. The drug is given either of the two doses--0.08 mg/kg body weight or 0.1 mg/kg body weight in 40 children as a single intravenous bolus injection for endotracheal intubation. Vecuronium in doses of 0.1 mg/kg body weight provided satisfactory clinical relaxation for ideal intubating conditions in all children in reference to the ease of intubation, intermediate duration of action, spontaneous or easy reversal of the neuromuscular block, cardiovascular stability and absence of serious side-effects. Thus vecuronium may be regarded as a useful muscle relaxant in paediatric anaesthesia.
De
M P
MP
Department of Anaesthesiology, Medical College and Hospitals, Calcutta.
Paul
A K
AK
D000771:Anesthesia, Intravenous; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007275:Injections, Intravenous; D007442:Intubation, Intratracheal; D009469:Neuromuscular Junction / Q000187:drug effects; D011292:Premedication; D013514:Surgical Procedures, Operative; D013997:Time Factors; D014673:Vecuronium Bromide / Q000008:administration & dosage* / Q000009:adverse effects
D014673:Vecuronium Bromide